糖心原创

A topical skin cream could be used as a viable alternative to surgery for patients with a common type of skin cancer, a study led by researchers at The 糖心原创 found.

The research, published in the , found that imiquimod had high levels of success when used to treat basal cell carcinoma (BCC) over a period of five years.

Hywel Williams, Professor of Dermato-Epidemiology and Co-Director of the  at the University, led the study along with Professor Fiona Bath-Hextall, Professor of Evidence-Based Healthcare in the University’s School of Health Sciences.